Article

jdsupra.com on 2021-06-02 22:41

Biogen and Bio-Thera Announce Positive Phase 3 Results On Tocilizumab Biosimilar

Biogen Inc. and Bio-Thera Solutions, Ltd. today announced positive Phase 3 results on BAT1806, a proposed biosimilar to ACTEMRA®/RoACTEMRA ...

Thera

Biogen Inc.

Related news

Biogen and Bio-Thera Solutions Announce Collaboration on Proposed Actemra® (Tocilizumab) Biosimilar jdsupra.com
Taiwan , Macau , Hong Kong , China
Biogen Announces EMA Acceptance of Tocilizumab Biosimilar Application jdsupra.com
China , Europe
Bio-Thera Solutions Announces Initiation of Phase III Clinical Trial for Tocilizumab Biosimilar jdsupra.com
California , United States , Switzerland
First Biosimilar Making “Paragraph IV” Certification under China’s New Patent Law: Bio-Thera Solutions Announced NMPA Acceptance of aBLA for Tocilizumab jdsupra.com
United States , China
First Patient Dosed with Stelara® biosimilar in Bio-Thera Solutions’ Phase III Clinical Trial for Moderate to Severe Psoriasis jdsupra.com
Biogen Announces FDA Approval of TOFIDENCE, a Tocilizumab Biosimilar Referencing ACTEMRA jdsupra.com
United States
FDA Accepts Bio-Thera Solutions’ Biologics License Application for BAT1706, a Proposed Biosimilar to Avastin®jdsupra.com
Bio-Thera Solutions and Hikma Pharmaceuticals Enters Into Ustekinumab Biosimilar Agreement jdsupra.com
Europe
Thera Drummond villages-news.com
Crossings , Tampa , The Villages , Manatee , Thera
GThera Moore guardonline.com
Batesville , Thera
FDA Approves Biogen Biosimilar for Genentech's Actemra®jdsupra.com
FDA Accepts for Review Fresenius Kabi’s BLA for Tocilizumab Biosimilar jdsupra.com
Genentech Files BPCIA Complaint Against Biogen Regarding Tocilizumab jdsupra.com
United States , Massachusetts
Deal news: Bio-Thera Solutions and Intract Pharma jdsupra.com
Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar jdsupra.com
California , United States , Switzerland
Fresenius Kabi Launches TYENNE, The First Approved Tocilizumab Biosimilar In The European Union jdsupra.com
Europe
Biosimilar Launch and Approval Updates – Tyenne® (tocilizumab-aazg), Xlucane™ (ranibizumab), Hercessi™ (trastuzumab-strf)jdsupra.com
Genentech and Biogen File Joint Stipulation of Dismissal in BPCIA Litigation Regarding Tocilizumab jdsupra.com
Massachusetts
Fresenius Kabi’s Actemra® biosimilar Tyenne® (tocilizumab-aazg) Approved in the U.S.jdsupra.com
Fresenius Kabi Announces Launch of TYENNE, a Tocilizumab Biosimilar Referencing ACTEMRA jdsupra.com
United States